Showing results (821-830 of 1,584) with videos related to
Sort By:
Pageof 159
European Journal of Nuclear Medicine and Molecular Imaging|May 13, 2010
Dose-response relationship in cyclophosphamide-treated B-cell lymphoma xenografts monitored with [18F]FDG PETLieselot Brepoels, Marijke De Saint-Hubert, Sigrid Stroobants, et al.Journal of Cellular Immunology|September 2, 2025
Inflammatory, Functional, and Compositional Changes of the Uterine Immune Microenvironment in a Lymphangioleiomyomatosis Mouse ModelDanielle S Stiene, Andrew R Osterburg, Lori B Corsarie, et al.Archives of Sexual Behavior|January 26, 2023
Prevent2Protect Project: Regulatory Focus Differences in Sexual Health Knowledge and PracticesDavid L Rodrigues, Richard O de Visser, Diniz Lopes, et al.Nucleosides & Nucleotides|August 5, 1999
Antitumor potential of acyclic nucleoside phosphonatesE De Clercq, G Andrei, J Balzarini, et al.Journal of Medicinal Chemistry|December 22, 1999
Potential multifunctional inhibitors of HIV-1 reverse transcriptase. Novel [AZT]-[TSAO-T] and [d4T]-[TSAO-T] heterodimers modified in the linker and in the dideoxynucleoside regionS Velázquez, V Tuñón, M L Jimeno, et al.Journal of Medicinal Chemistry|September 27, 1996
Acyclic nucleotide analogs derived from 8-azapurines: synthesis and antiviral activityA Holý, H Dvoráková, J Jindrich, et al.Journal of Medicinal Chemistry|September 4, 1992
Synthesis and antiviral properties of (+/-)-5'-noraristeromycin and related purine carbocyclic nucleosides. A new lead for anti-human cytomegalovirus agent designS D Patil, S W Schneller, M Hosoya, et al.The Journal of Biological Chemistry|April 11, 2003
Crystal structure of varicella zoster virus thymidine kinaseLouise E Bird, Jingshan Ren, Alan Wright, et al.Virology|July 1, 1992
Sulfated polymers inhibit the interaction of human cytomegalovirus with cell surface heparan sulfateJ Neyts, R Snoeck, D Schols, et al.The International Journal of Biochemistry & Cell Biology|June 9, 2004
Obligatory involvement of CD26/dipeptidyl peptidase IV in the activation of the antiretroviral tripeptide glycylprolylglycinamide (GPG-NH(2))Jan Balzarini, Elin Andersson, Dominique Schols, et al.Pageof 159